全文获取类型
收费全文 | 374457篇 |
免费 | 34810篇 |
国内免费 | 26032篇 |
专业分类
耳鼻咽喉 | 2844篇 |
儿科学 | 4896篇 |
妇产科学 | 4195篇 |
基础医学 | 41043篇 |
口腔科学 | 6135篇 |
临床医学 | 52882篇 |
内科学 | 50701篇 |
皮肤病学 | 4137篇 |
神经病学 | 18168篇 |
特种医学 | 13778篇 |
外国民族医学 | 224篇 |
外科学 | 33086篇 |
综合类 | 69962篇 |
现状与发展 | 86篇 |
一般理论 | 31篇 |
预防医学 | 27574篇 |
眼科学 | 10672篇 |
药学 | 40692篇 |
432篇 | |
中国医学 | 24363篇 |
肿瘤学 | 29398篇 |
出版年
2024年 | 1273篇 |
2023年 | 5460篇 |
2022年 | 14407篇 |
2021年 | 18282篇 |
2020年 | 14408篇 |
2019年 | 11689篇 |
2018年 | 12168篇 |
2017年 | 11673篇 |
2016年 | 10779篇 |
2015年 | 16834篇 |
2014年 | 20952篇 |
2013年 | 19057篇 |
2012年 | 28356篇 |
2011年 | 31877篇 |
2010年 | 21508篇 |
2009年 | 17505篇 |
2008年 | 21389篇 |
2007年 | 21117篇 |
2006年 | 20139篇 |
2005年 | 19233篇 |
2004年 | 12701篇 |
2003年 | 12232篇 |
2002年 | 10004篇 |
2001年 | 8532篇 |
2000年 | 8320篇 |
1999年 | 8393篇 |
1998年 | 5300篇 |
1997年 | 5097篇 |
1996年 | 3958篇 |
1995年 | 3716篇 |
1994年 | 3136篇 |
1993年 | 2028篇 |
1992年 | 2428篇 |
1991年 | 2126篇 |
1990年 | 1793篇 |
1989年 | 1559篇 |
1988年 | 1285篇 |
1987年 | 1184篇 |
1986年 | 956篇 |
1985年 | 678篇 |
1984年 | 369篇 |
1983年 | 272篇 |
1982年 | 142篇 |
1981年 | 169篇 |
1980年 | 115篇 |
1979年 | 154篇 |
1978年 | 73篇 |
1977年 | 53篇 |
1974年 | 42篇 |
1972年 | 37篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
101.
102.
BackgroundArtificial insemination with the husband’s semen (AIH) is an economical and noninvasive method of infertility treatment. However, AIH’s pregnancy rate is much lower than in vitro fertilization (IVF) as its multiple and complex uncertainty factors. Semen quality has been one of the main factors which affect the pregnancy outcome of AIH.MethodsThe relevant parameters of 1,142 AIH cycles were retrospectively studied, including the general parameters and the semen quality parameters among clinical pregnancy, biochemical pregnancy, non-pregnancy group, age, infertility duration, infertility type, body mass index (BMI), cycle count, morphology in previously semen examination, and semen quality parameters on the day of AIH.ResultsThe statistically significant difference was only found on processed total non-forward and non-motile sperm count (N-TFMSC). The mean processed N-TFMSC in the biochemical pregnancy group was 6.37±4.27 million, significantly higher than the other two groups (vs. 4.40±3.15 million or vs. 4.48±3.60 million, P<0.05). The study was then divided into two groups according to processed N-TFMSC, Group 1 ≤5.0 million, and Group 2 >5.0 million. A statistical increase in biochemical pregnancy rate was observed when the processed N-TFMSC was >5.0 million (2.72% vs. 0.90%).ConclusionsProcessed N-TFMSC may be one of the independent factors on AIH’s outcome; it should be given equal attention the same as processed total forward motile sperm count (TFMSC). 相似文献
103.
Xiaoqing Guo Ji-Eun Seo Xilin Li Nan Mei 《Journal of toxicology and environmental health. Part B, Critical reviews》2020,23(1):27-50
ABSTRACTGenotoxic compounds may be detoxified to non-genotoxic metabolites while many pro-carcinogens require metabolic activation to exert their genotoxicity in vivo. Standard genotoxicity assays were developed and utilized for risk assessment for over 40 years. Most of these assays are conducted in metabolically incompetent rodent or human cell lines. Deficient in normal metabolism and relying on exogenous metabolic activation systems, the current in vitro genotoxicity assays often have yielded high false positive rates, which trigger unnecessary and costly in vivo studies. Metabolically active cells such as hepatocytes have been recognized as a promising cell model in predicting genotoxicity of carcinogens in vivo. In recent years, significant advances in tissue culture and biological technologies provided new opportunities for using hepatocytes in genetic toxicology. This review encompasses published studies (both in vitro and in vivo) using hepatocytes for genotoxicity assessment. Findings from both standard and newly developed genotoxicity assays are summarized. Various liver cell models used for genotoxicity assessment are described, including the potential application of advanced liver cell models such as 3D spheroids, organoids, and engineered hepatocytes. An integrated strategy, that includes the use of human-based cells with enhanced biological relevance and throughput, and applying the quantitative analysis of data, may provide an approach for future genotoxicity risk assessment. 相似文献
104.
105.
106.
107.
108.
109.